Inicure
Pre-clinicalDeveloping small molecule FPR agonists to treat infectious diseases and combat the growing threat of resistant bacterial infections
Founded
2018
Focus
Small Molecules
About
Developing small molecule FPR agonists to treat infectious diseases and combat the growing threat of resistant bacterial infections
Company Info
TypePrivate
Founded2018
LocationStockholm, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile